Guerrab Walid, El Jemli Meryem, Akachar Jihane, Demirtaş Güneş, Mague Joel T, Taoufik Jamal, Ibrahimi Azeddine, Ansar M'Hammed, Alaoui Katim, Ramli Youssef
Laboratory of Medicinal Chemistry, Drug Sciences Research Center, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat, Morocco.
Laboratory of Pharmacology and Toxicology, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat, Morocco.
J Biomol Struct Dyn. 2022;40(19):8765-8782. doi: 10.1080/07391102.2021.1922096. Epub 2021 May 10.
The hydantoin scaffold is of substantial importance and it is commonly used in drug discovery. Herein, we report the synthesis of a novel phenytoine (a hydantoin derivative) with high yield by the reaction of phenytoin with 1-bromodecyl agent. Namely, 3-decyl-5,5- diphenylimidazolidine-2,4-dione (3DDID). The optimized geometry of the compound was calculated using density functional theory (DFT) method by B3LYP with 6-311++G(d,p) basis set. For this calculation, the X-ray data were used as initial values. Molecular electrostatic potential (MEP) surface and Frontier molecular orbitals (FOMs) were prepared for the compound. The crystal structure of the title compound contains intermolecular N-H···O, C-H···O hydrogen bonds and weak C-H···π interactions. Hirshfeld surface analysis and 2D fingerprint plots of the molecule aid comparison of intermolecular interactions and these analysis reveals that two close contacts are associated with intermolecular hydrogen bonds. The psychotropic activity evaluation of the synthesized compound was further explored using hole bored test for exploratory behaviors, dark//light box test for anxiolytic activity and Rota-road, traction, chimney testes were used to assess the myrelaxant effect. In addition, molecular modeling study was also conducted to rationalize the potential as neurotherapeutic drugs of our synthesized compound by predicting their binding modes, binding affinities and optimal orientation at the active site of the GABA-A receptor and Na channel. Finally, ADMET predictions was also examined. HighlightsSynthesis, structural, and molecular characterization of a novel phenytoin derivative.DFT, XRD, and the Hirshfeld surface analysis of crystal structure was studied.Acute toxicity and psychotropic activity evaluation of 3-decyl-5,5 diphenylimidazolidine-2,4-dione (3DDID).Molecular modeling studies have been conducted to rationalize the obtained data and to determine the probable binding mode.Communicated by Ramaswamy H. Sarma.
乙内酰脲骨架非常重要,常用于药物研发。在此,我们报道了通过苯妥英与1-溴癸烷试剂反应高产率合成一种新型苯妥英(一种乙内酰脲衍生物)。即3-癸基-5,5-二苯基咪唑烷-2,4-二酮(3DDID)。使用密度泛函理论(DFT)方法,采用B3LYP并结合6-311++G(d,p)基组计算了该化合物的优化几何结构。对于此计算,将X射线数据用作初始值。为该化合物制备了分子静电势(MEP)表面和前线分子轨道(FOMs)。标题化合物的晶体结构包含分子间N-H···O、C-H···O氢键和弱C-H···π相互作用。分子的 Hirshfeld 表面分析和二维指纹图谱有助于比较分子间相互作用,这些分析表明两个紧密接触与分子间氢键有关。使用钻孔试验评估探索行为、明暗箱试验评估抗焦虑活性以及旋转棒、牵引、烟囱试验评估肌肉松弛作用,进一步探索了合成化合物的精神活性。此外,还进行了分子建模研究,通过预测它们在GABA-A受体和Na通道活性位点的结合模式、结合亲和力和最佳取向,来合理化我们合成化合物作为神经治疗药物的潜力。最后,还研究了ADMET预测。要点新型苯妥英衍生物的合成、结构和分子表征。研究了晶体结构的DFT、XRD和Hirshfeld表面分析。3-癸基-5,5-二苯基咪唑烷-2,4-二酮(3DDID)的急性毒性和精神活性评估。进行了分子建模研究以合理化所得数据并确定可能的结合模式。由Ramaswamy H. Sarma传达。